Shh genetic deletion, or chronic treatment with a hedgehog inhibitor, in mice presenting with an intra-pancreatic mutation of Kras and p53, accelerated pancreatic tumour progression and reduced survival, with tumours presenting a poorly differentiated histology and increased vascularity (Rhim et al, 2014). Here, TP53 is linked to neoplasm.